{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-331409","form_type":"8-K","ticker":"INAB","cik":"0001740279","company_name":"IN8BIO, INC.","filed_at":"2021-11-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.903873+00:00","generated_at":"2026-06-28T07:26:10.880623+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"IN8bio appoints Dr. Trishna Goswami as Chief Medical Officer","bullets":["Annual base salary of $450,000; eligible for annual bonus targeted at 40% of base; signing bonus $10,000.","Awarded option to purchase 250,000 shares vesting over 4 years (25% at year 1).","Severance includes 12 months base salary, prorated target bonus, and 9 months COBRA if terminated without cause or for good reason.","Dr. Goswami previously led Trodelvy approvals at Gilead/Immunomedics; also worked at Stemline and AstraZeneca/MedImmune.","Appointment effective November 15, 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-331409","json":"https://secwatch.observer/filing/0001193125-21-331409.json","markdown":"https://secwatch.observer/filing/0001193125-21-331409.md","text":"https://secwatch.observer/filing/0001193125-21-331409.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1740279/000119312521331409/0001193125-21-331409-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1740279/000119312521331409/d238625d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T07:26:10.880623+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9f3a86de0a","claim":"Trishna Goswami was appointed as Chief Medical Officer at IN8BIO, INC..","evidence_excerpt":"Effective as of November 15, 2021, IN8bio, Inc. (the “ Company ”) appointed Dr. Trishna Goswami as the Company’s Chief Medical Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1740279/000119312521331409/0001193125-21-331409-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}